Search research articles
Contact Us
Filters
Showing results (261-270 of 276) with videos related to
Page
of 28
Sort By:
Iscience
|
February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base
Hongying Duan, Angela R Corrigan, Cheng Cheng, et al.
European Urology
|
March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer
Brian F Chapin, Marc Smaldone, Amado J Zurita, et al.
Nature Communications
|
July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications
|
April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Cancer Cell
|
May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancer
Courtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
JCI Insight
|
November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Nature Communications
|
April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 276) with videos related to
Sort By:
Page
of 28
Iscience
|
February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base
Hongying Duan, Angela R Corrigan, Cheng Cheng, et al.
European Urology
|
March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer
Brian F Chapin, Marc Smaldone, Amado J Zurita, et al.
Nature Communications
|
July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications
|
April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Cancer Cell
|
May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancer
Courtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
JCI Insight
|
November 25, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Nature Communications
|
April 5, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Page
of 28